The global Exenatide Market is experiencing substantial growth due to increasing diabetes cases and advancements in drug formulations. The market is expected to expand at a robust pace, driven by rising healthcare expenditure, increasing awareness about diabetes management, and the growing adoption of GLP-1 receptor agonists. According to DataIntelo, the Exenatide Market was valued at USD XX...

GLP-1 Receptor Agonist Industry The global GLP-1 receptor agonist market size is expected to reach USD 156.71 billion by 2030, expanding at a CAGR of 17.46% from 2025 to 2030, according to a new report by Grand View Research, Inc. The strong product pipeline and formulation advancements are driving the market. In addition, novel innovative products are booming the market. In September...

Glucagon-like peptide-1 (GLP-1) drugs have emerged as a revolutionary class of medications in the treatment of type 2 diabetes and obesity. These drugs, known as GLP-1 receptor agonists, mimic the natural hormone GLP-1 that the body produces in response to food intake. The hormone plays a key role in regulating blood sugar levels, promoting satiety, and slowing gastric emptying. Originally...